Long term treatment of depression with selective serotonin reuptake inhibitors and newer antidepressants.
about
A 10-year analysis of the effects of media coverage of regulatory warnings on antidepressant use in The Netherlands and UKIncreased anxiety in corticotropin-releasing factor type 2 receptor-null mice requires recent acute stress exposure and is associated with dysregulated serotonergic activity in limbic brain areas.Antidepressant medication use, weight gain, and risk of type 2 diabetes: a population-based study.Antidepressant use and risk of coronary heart disease: meta-analysis of observational studies.Fluoxetine prevents development of an early stress-related molecular signature in the rat infralimbic medial prefrontal cortex. Implications for depression?Anti-depressant medication use and C-reactive protein: results from two population-based studiesExperiences from consumer reports on psychiatric adverse drug reactions with antidepressant medication: a qualitative study of reports to a consumer associationAntidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey.Antidepressant use and risk of adverse outcomes in older people: population based cohort study.Antidepressant medication use and risk of hyperglycemia and diabetes mellitus: a noncausal association?Consumer Narratives in ADR Reporting: An Important Aspect of Public Health? Experiences from Reports to a Swedish Consumer OrganizationSerotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-AnalysisA Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Levomilnacipran ER 40-120mg/day for Prevention of Relapse in Patients with Major Depressive Disorder.Long-term antidepressant use: patient perspectives of benefits and adverse effects.Antidepressant medication use and trajectories of fasting plasma glucose, glycated haemoglobin, β-cell function and insulin sensitivity: a 9-year longitudinal study of the D.E.S.I.R. cohort.Low-dose escitalopram-associated hyponatremia.Benefit of slow titration of paroxetine to treat depression in the elderly.Investigating the roles of different monoamine transmitters and impulse control using the 5-choice serial reaction time task.Methodological Flaws, Conflicts of Interest, and Scientific Fallacies: Implications for the Evaluation of Antidepressants' Efficacy and Harm.Persistence with pharmacological treatment in the specialist mental healthcare of patients with severe mental disorders.Economic impact of antidepressant treatment duration in naturalistic conditions.Depression, antidepressant treatment and the cardiovascular system.Does obesity really protect against psychological distress? Examining the ‘fat-jolly’ versus ‘fat-sad’ hypotheses using Mendelian randomizationEye Movement Desensitization and Reprocessing Versus Treatment as Usual in the Treatment of Depression: A Randomized-Controlled Trial
P2860
Q28483908-83D42676-3F24-4EB8-B6C9-08AB8DA7C04FQ30438084-C55074F2-F427-43F1-A7B3-C4847C319541Q34351813-D38D3992-A943-4654-97FD-2C91CBC0C74FQ34410894-37B9D400-E9FB-41BE-9567-C91F52CE5F48Q34449524-B1CCD3C7-F35F-43F6-9B56-1C0946AB2B40Q34459786-6B2E5528-B3D4-49C7-90FA-54E63C5781F7Q34519989-E74564C0-D3E5-41F3-B587-181A6EC234C5Q34571252-45B92F63-3475-4814-B803-AED077E2D177Q35144173-C6C6DBC7-B19B-496D-86FD-20DFE0BE3175Q35456399-367C79CF-11EC-48DB-B98F-FF3F9F53EB61Q36015119-71816A18-5891-4F00-9CBC-C690E9F11D9AQ36123663-47DFCE55-A703-4599-B13E-4969A4414E04Q37651165-8D35F1D0-64CF-4977-9955-2AB6D064D992Q39486415-11F5EA43-9415-45E1-BDE3-3C534D4C9501Q40657746-E31BF761-B9EF-4323-AA13-712D5A5E088EQ44020670-CCF0A4D0-0D79-4BA5-A50A-EABD9B5B8503Q46052044-56C0A8F4-8F0C-4594-A19F-F8573EBEF5EFQ46649081-3A197B5C-6A40-400D-B18E-3ED0DAC16500Q47098457-3A7148A8-26EA-49B8-A610-9F5797F9DA6EQ47785684-D0F92C6E-1A8D-4D31-9DB5-C6AA9985D3A9Q48574203-41338646-22F4-4A16-9BFC-0F8A695B2616Q57253298-808AA918-4F52-47A7-803F-B012A2815470Q57315420-8683BAEE-989C-4B20-887F-866CDAA42FC0Q58780452-A7CF201B-8A8A-41BB-835D-44AC3C99D179
P2860
Long term treatment of depression with selective serotonin reuptake inhibitors and newer antidepressants.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Long term treatment of depress ...... ors and newer antidepressants.
@en
Long term treatment of depress ...... ors and newer antidepressants.
@nl
type
label
Long term treatment of depress ...... ors and newer antidepressants.
@en
Long term treatment of depress ...... ors and newer antidepressants.
@nl
prefLabel
Long term treatment of depress ...... ors and newer antidepressants.
@en
Long term treatment of depress ...... ors and newer antidepressants.
@nl
P356
P1433
P1476
Long term treatment of depress ...... ors and newer antidepressants.
@en
P2093
Corrado Barbui
Steven Reid
P356
10.1136/BMJ.C1468
P407
P577
2010-03-26T00:00:00Z